Biodel Revenue and Competitors
Estimated Revenue & Valuation
- Biodel's estimated annual revenue is currently $2.8M per year.
- Biodel's estimated revenue per employee is $155,000
Employee Data
- Biodel has 18 Employees.
- Biodel grew their employee count by -25% last year.
Biodel's People
Name | Title | Email/Phone |
---|
Biodel Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.1M | 30 | -19% | N/A | N/A |
What Is Biodel?
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company's website at www.biodel.com.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biodel News
B. Braun, Becton, Dickinson, Biocon, Biodel, ELI Lilly, Julphar, NOVO Nordisk, Sanofi, Wockhardt, Ypsomed. This comprehensive Human Insulin Market report...
Biodel; Boehringer Ingelheim; Diamyd Therapeutics AB. The research includes various geographical categorizations as well as a detailed examination of all...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 18 | N/A | N/A |
#2 | N/A | 19 | -10% | N/A |
#3 | $4.6M | 20 | -17% | N/A |
#4 | $4.2M | 22 | -19% | N/A |
#5 | N/A | 23 | 109% | N/A |